AI summary by TwinMind

How one scientist averted a national health crisis - Andrea Tone

TED-Ed

5m 32s

Frances Kelsey's Background and Education

  • Fall 1960: Joined FDA as newest recruit
  • Graduated high school at age 15
  • McGill University Montreal: undergraduate and master's degrees in pharmacology
  • University of Chicago pharmacology department: applied for research post
    • Acceptance letter addressed to "Mr. Oldham" (gender confusion)
    • Joked career might have ended if named Elizabeth or Mary Jane
  • Earned doctorate in pharmacology at Chicago
  • Stayed as faculty, conducted pioneering research on drugs and fetal safety
  • 1950: Earned MD (fourth and final degree)
  • By FDA joining: one of most educated, experienced scientists around

Thalidomide Assignment and Initial Review

  • Assigned "easy review" as newest team member
  • Application from US drug company Merrell to sell thalidomide
  • Thalidomide: sedative developed in Germany
    • Already widely used in dozens of countries
    • Treated insomnia and workplace stress
    • Anti-nausea properties made it popular for pregnant women with morning sickness
  • Kelsey found Merrell's data on absorption and toxicity inadequate
  • 1960: Many experts believed placental barrier shielded fetus from harm
  • Kelsey's earlier animal research demonstrated opposite: drugs could pass mother to fetus through placenta
  • Merrell had not tested drug on pregnant animals (standard practice at time)
  • Kelsey said evidence seemed "more like testimonials than results of well-designed studies"

FDA Review Process and Merrell's Response

  • Kelsey rejected Merrell's application, requested second application with better evidence
  • FDA colleagues supported decision
  • Merrell expected quick approval for holiday season launch (sedative sales soar)
  • Instead of providing requested data, Merrell tried convincing Kelsey through calls and visits
  • Merrell executives complained Kelsey was "stubborn and nit-picking"
  • FDA backed Kelsey, forcing Merrell to file multiple applications

Thalidomide Adverse Effects Discovery

  • Early 1961: Doctors reported nerve damage cases
  • Fall 1961: Uncovered severe birth defects in pregnant women users
  • Thousands of babies died in utero
  • Tens of thousands born with:
    • Extra appendages
    • Shorter limbs
    • No limbs at all
  • November 1961: Thalidomide pulled from German market
  • Merrell continued US approval attempts for several months before withdrawing sixth and final application

Impact and Recognition

  • Kelsey kept thalidomide off multi-billion-dollar American drug market
  • Became media sensation as public awareness grew
  • Headlines heralded her heroism in newspapers and magazines
  • President John F. Kennedy presented her award on White House lawn
  • Post-thalidomide: Congress passed laws expanding FDA authority and toughening new drug application requirements
  • Kelsey appointed to head agency's drug investigation branch
  • Worked at FDA in different capacities into her 90s
  • Legacy: privileging facts over opinions, patience over shortcuts, making evidence-based medicine foundation of continuing reforms

TwinMind

Get summaries like this for your own meetings

TwinMind takes notes in the background during meetings, lectures, and calls, then writes the summary for you.

Free plan to get started

No bot joins your calls

Phone, desktop & Chrome apps

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome